Cargando…

Enhancing Prediction Performance by Add-On Combining Circulating Tumor Cell Count, CD45(neg) EpCAM(neg) Cell Count on Colorectal Cancer, Advance, and Metastasis

SIMPLE SUMMARY: Information describing circulating tumor cells (CTCs) holds promise for clinical applications. However, conventional CTCs enumeration could ignore the CTCs more relevant to cancer metastasis. Thus, negative selection CTC enumeration was proposed, by which information on the numbers o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Sherry Yueh-Hsia, Hsieh, Chia-Hsun, You, Jeng-Fu, Chu, Po-Yu, Hung, Hsin-Yuan, Chu, Pao-Hsien, Wu, Min-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196640/ https://www.ncbi.nlm.nih.gov/pubmed/34063929 http://dx.doi.org/10.3390/cancers13112521

Ejemplares similares

An Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic System for the Isolation of High-Purity CD45(neg)/EpCAM(neg) Cells from the Blood Samples of Cancer Patients—Demonstration and Initial Exploration of the Clinical Significance of These Cells
por: Liao, Chia-Jung, et al.
Publicado: (2018)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)

Operating/regenerating the beam screen and the NEG
por: Rossi, A
Publicado: (2003)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2015)

La Transfusione del Sangue negli alienati
por: Pouza, G. L.
Publicado: (1875)

Verificata negli USA la teoria di Weinberg e Salam. La "violazione della parit\141" negli atomi
por: Maiani, Luciano
Publicado: (1978)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
por: Chantima, Warangkana, et al.
Publicado: (2017)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020)

Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

EpCAM as Modulator of Tissue Plasticity
por: Fagotto, François
Publicado: (2020)

Tumor-Derived Exosomes Regulate Apoptosis of CD45(+)EpCAM(+) Cells in Lung Cancer
por: Lu, Shixiang, et al.
Publicado: (2022)

EpCAM and the biology of hepatic stem/progenitor cells
por: Dollé, Laurent, et al.
Publicado: (2014)

Outgassing measurement of an LHC collimator and estimation for the NEG performances
por: Kamiya, Junichiro, et al.
Publicado: (2011)

Calcul du pompage effectif des modules NEG
por: Laurent, J M
Publicado: (1983)

Difficultés avec les passages de courant NEG
por: Lawrence, J M
Publicado: (1987)

Sey and electron cloud build-up with neg materials
por: Rossi, A
Publicado: (2005)

An UHV transportable container based on a NEG pump
por: Daccà, A, et al.
Publicado: (1999)

Saturation behaviour of the LHC NEG coated beam pipes
por: Porcelli, T, et al.
Publicado: (2012)

Single Bunch Instabilities and NEG Coating for FCC-ee
por: Belli, Eleonora, et al.
Publicado: (2019)

Emergence of AnnexinV(pos) CD31(neg) CD42b(low/neg) extracellular vesicles in plasma of humans at extreme altitude
por: Utermöhlen, Olaf, et al.
Publicado: (2019)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

Current View on EpCAM Structural Biology
por: Gaber, Aljaž, et al.
Publicado: (2020)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
por: Chen, Serena H., et al.
Publicado: (2021)

EpCAM(low) Circulating Tumor Cells: Gold in the Waste
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

Particelle fortemente ionizzanti negli sciami dei raggi cosmici
por: Cocconi, Giuseppe
Publicado: (1941)

Pumping speed of sputter ion pumps modified with NEG modules
por: Kersevan, Roberto, et al.
Publicado: (1992)

Initial activation of EpCAM cleavage via cell-to-cell contact
por: Denzel, Sabine, et al.
Publicado: (2009)

Circulating CD45(+)EpCAM(+) cells as a diagnostic marker for early-stage primary lung cancer
por: Sun, Zhen, et al.
Publicado: (2022)

EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
por: Beta, Madhu, et al.
Publicado: (2014)

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
por: Bagheri, Andisheh, et al.
Publicado: (2022)

EpCAM proteolysis: new fragments with distinct functions?
por: Schnell, Ulrike, et al.
Publicado: (2013)

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)

Functions of EpCAM in physiological processes and diseases (Review)
por: Huang, Li, et al.
Publicado: (2018)

Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
por: Mohtar, M. Aiman, et al.
Publicado: (2020)

Effects of EpCAM overexpression on human breast cancer cell lines
por: Gostner, Johanna M, et al.
Publicado: (2011)

Correction: EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0hvq1858qiaqg7ps5bgfoqhupv